HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James T McCracken Selected Research

SLI381

8/2005A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.
6/2005Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.
6/2003Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.
6/2003Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James T McCracken Research Topics

Disease

36Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2019 - 05/2002
21Autism Spectrum Disorder
01/2022 - 01/2005
20Autistic Disorder (Autism)
12/2020 - 08/2002
7Anxiety Disorders (Anxiety Disorder)
01/2022 - 01/2010
7Weight Gain
01/2016 - 08/2002
5Tics (Tic)
01/2022 - 01/2008
5Tourette Syndrome (Tourette's Syndrome)
01/2022 - 01/2004
5Major Depressive Disorder (Major Depressive Disorders)
03/2011 - 11/2004
4Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
11/2017 - 08/2005
3Social Phobia
08/2017 - 01/2010
3Fatigue
01/2016 - 08/2002
3Schizophrenia (Dementia Praecox)
01/2015 - 08/2002
3Mental Disorders (Mental Disorder)
01/2015 - 08/2005
2Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2017 - 12/2008
2Sleepiness
01/2016 - 12/2005
2Separation Anxiety (Separation Anxiety Disorder)
04/2014 - 01/2010
2Sleep Initiation and Maintenance Disorders (Insomnia)
06/2009 - 06/2005
2Sialorrhea
12/2005 - 08/2002
1Disorders of Excessive Somnolence (Hypersomnia)
01/2022
1Neurodevelopmental Disorders
01/2021
1Medically Unexplained Symptoms
01/2018
1Trichotillomania
04/2017
1Excoriation Disorder
04/2017
1Learning Disabilities (Learning Disability)
01/2017
1Insulin Resistance
01/2016
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016
1Lethargy
01/2016
1Weight Loss (Weight Reduction)
11/2015
1Pervasive Child Development Disorders
07/2015
1Fragile X Syndrome (Martin Bell Syndrome)
04/2014
1Treatment-Resistant Depressive Disorder
03/2011
1Diarrhea
06/2009

Drug/Important Bio-Agent (IBA)

14Risperidone (Risperdal Consta)FDA LinkGeneric
12/2016 - 08/2002
12Methylphenidate (Ritalin)FDA LinkGeneric
12/2018 - 02/2007
8Guanfacine (Tenex)FDA LinkGeneric
01/2018 - 02/2010
7Pharmaceutical PreparationsIBA
09/2021 - 06/2005
7Biomarkers (Surrogate Marker)IBA
12/2020 - 09/2009
7Antipsychotic Agents (Antipsychotics)IBA
11/2015 - 08/2002
5Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2022 - 06/2009
5Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
01/2019 - 08/2005
5Sertraline (Zoloft)FDA LinkGeneric
01/2018 - 01/2010
4CitalopramFDA LinkGeneric
01/2022 - 06/2009
4Dopamine (Intropin)FDA LinkGeneric
04/2010 - 08/2002
4SLI381IBA
08/2005 - 06/2003
4Amphetamine (Amfetamine)FDA LinkGeneric
08/2005 - 06/2003
3Glutamic Acid (Glutamate)FDA Link
11/2017 - 01/2012
3SaltsIBA
08/2005 - 06/2003
2MelatoninIBA
01/2022 - 01/2018
2Cycloserine (Seromycin)FDA Link
11/2020 - 01/2017
2gamma-Aminobutyric Acid (GABA)IBA
01/2018 - 04/2014
2(6- chloro- 1- (2- (dimethylamino)ethyl)indol- 3- yl)- spiro(1H- isobenzofuran- 3,4'- piperidine)- 1'- yl- methanoneIBA
08/2017 - 08/2017
2Vasopressins (Vasopressin)IBA
08/2017 - 08/2017
2Choline (Choline Chloride)IBA
04/2013 - 12/2003
22- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
10/2010 - 07/2010
2Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
12/2009 - 08/2009
2Antidepressive Agents (Antidepressants)IBA
09/2009 - 01/2005
2Protons (Proton)IBA
04/2004 - 12/2003
2AdderallIBA
06/2003 - 06/2003
1Dopamine D2 Receptor AntagonistsIBA
01/2018
1ecopipamIBA
01/2018
1Dopamine AntagonistsIBA
01/2018
1Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
08/2017
1dixanthogen (EXD)IBA
04/2017
16-pyruvoyltetrahydropterin synthase (PTPS)IBA
01/2017
1Dexmethylphenidate HydrochlorideFDA LinkGeneric
12/2016
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2016
1Insulin (Novolin)FDA Link
01/2016
1Hemoglobins (Hemoglobin)IBA
01/2016
1LeptinIBA
01/2016
1Glucose (Dextrose)FDA LinkGeneric
01/2016
1Alanine Transaminase (SGPT)IBA
01/2016
1IronIBA
11/2015
1Acetyl Coenzyme A (Acetyl-CoA)IBA
04/2013
1Dopamine Agonists (Dopamine Agonist)IBA
04/2013
1Inositol (Myoinositol)IBA
04/2013
1Lactic Acid (Lactate)FDA LinkGeneric
04/2013
1ElementsIBA
03/2013
1Interleukin-13IBA
12/2011
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
12/2011
1InterleukinsIBA
12/2011
1Interleukin-1 (Interleukin 1)IBA
12/2011
1InterferonsIBA
12/2011
1Epidermal Growth Factor (EGF)IBA
12/2011
1Interleukin-17 (Interleukin 17)IBA
12/2011
1Oxytocin (Pitocin)FDA LinkGeneric
08/2011
1NeuropeptidesIBA
08/2011
1Amino Acid Transport System X-AG (Glutamate Transporter)IBA
06/2011
1Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
03/2011
1Dopamine Receptors (Dopamine Receptor)IBA
04/2010
1ManganeseIBA
04/2010
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
12/2009
1Monoamine Oxidase (MAO)IBA
08/2009

Therapy/Procedure

8Therapeutics
01/2017 - 08/2002
3Drug Therapy (Chemotherapy)
01/2018 - 01/2005
2Combined Modality Therapy
12/2018 - 12/2017
2Transcranial Magnetic Stimulation
02/2016 - 01/2014
1Phototherapy (Light Therapy)
01/2022
1Traction
01/2021
1Cognitive Training
01/2017
1Electrodes (Electrode)
08/2009